Business Wire

PA-CMMI-INSTITUTE

31.10.2016 22:34:18 CET | Business Wire | Press release

Share
Connect with Global Business Leaders Dedicated to Performance Improvement at the Capability Counts 2017 Conference in Washington, DC

According to a 2016 PwC CEO Survey, CEOs are seeking to better measure the impact and value of innovation for their key stakeholders. Companies are addressing these challenges by gaining better insight into business processes.

The CMMI Institute is addressing how investing in business and process improvement builds capability at their annual Capability Counts Conference on 16 & 17 May 2017 in Alexandria, VA, just outside of Washington, DC. The conference will feature the latest market trends and success stories on how to streamline business processes and create a culture of continuous improvement.

The conference will offer a series of collaborative workshops, engaging keynotes, and interactive panel discussions focused on delivering actionable insights on what it means to be a capable organization. Hundreds of professionals dedicated to performance and capability improvement from an array of backgrounds, countries, and experiences are expected to attend.

According to a 2016 Boston Consulting Group article, companies often focus too much on the finish line and not enough on capabilities, the muscles they need to build and strengthen in order to get and—most importantly—to stay ahead.

“If you want to compete, you have to improve performance. If you want to improve performance, you have to increase capability. If you want to increase capability, you have to attend this conference,” states Michael West, Program Chair and Founder and President of Natural SPI.

Capability Counts 2017 will offer six tracks, providing best practices and solutions for professionals of all levels who are responsible for elevating performance in their organization. Additionally, half-day tutorials, the 2nd Annual Capability Challenge, and private coaching sessions add value to the conference experience. Attendees can customize their two-day schedule by selecting sessions from six tracks :

  • CMMI On Board - This track is for those already on their capability journey and features case studies from organizations who have delivered successful products or projects while using CMMI.
  • Advancing Your Capability - This track is for those with advanced skills in capability management and improvement. It will focus on how organizations leverage their capability, outpace the competition, and demonstrate best practices.
  • CMMI Appraisals - This track features experienced professionals who will share their knowledge and help individuals and their organizations start their CMMI journey and how to plan and conduct high-value CMMI appraisals. This track is for those planning their first appraisal or in the process of getting a reappraisal.
  • CMMI Adoption by Industry - This track features presentations on CMMI adoption and capability improvement across industry sectors (e.g. Aerospace and Defense, Banking and Finance, IT, and Research, etc.).
  • Total Solution - This track features presentations with CMMI adoption and implementation with other models, standards, bodies of knowledge, and methods (e.g. ISO-based standards, agile, PMBoK®, and ITIL).
  • Discipline-Focused Capability - This track is focused on professional discipline adoption of CMMI (e.g. Software development and agile, process design and development, program and project management, and workforce development and training).

To get professionals ready for the conference, the second annual webinar series, The Capability Challenge, is kicking off in December 2016. The Capability Challenge is a competition that features compelling stories of organizations building capability and improving performance. This webinar series will be held from December to April 2017 featuring the Capability Challenge participants telling their business success stories. The finals will be held at the Capability Counts 2017 conference in May and the Capability Challenge Champion will be announced in front of all conference attendees. AEGIS.net won the first ever Capability Challenge and was honored at the 2016 conference. CMMI Institute recognized AEGIS’s achievement with a video  of their CMMI success story, "Building a More Powerful Business Through CMMI”.

Capability Counts 2017 will offer conference attendees ready-to-use resources, tools, and best practices from industry experts to share with their organization. There are many opportunities to get an ROI from your professional development investment at this premier conference. Get a glimpse of what to expect from a CMMI Institute Conference and view the highlight video .

For more information on the CMMI Institute Capability Counts 2017 Conference or for registration details, visit http://CMMIConferences.com .

Do you have a CMMI story that articulates clear goals and highlights measurable results? Submit a paper to present at Capability Counts 2017: http://cmmiinstitute.com/conferences#callforpapers .

About CMMI ® Institute

CMMI Institute (CMMIinstitute.com) is the global leader in the advancement of best practices in people, process, and technology. The Institute provides the tools and support for organizations to benchmark their capabilities and build maturity by comparing their operations to best practices and identifying performance gaps. For over 25 years, thousands of high-performing organizations in a variety of industries, including aerospace, finance, healthcare, software, defense, transportation, and telecommunications, have earned a CMMI maturity level rating and proved they are capable business partners and suppliers. CMMI Institute is a part of the ISACA family, the global non-profit association helping professionals to realize the positive potential of technology. To learn more about how CMMI can help your organization elevate performance, visit CMMIinstitute.com .

Contact:

CMMI Institute
Chavonne Hoyle, 215-353-6524
choyle@cmmiinstitute.com

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release

Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas

ICE Brent and ICE WTI Perpetual Futures to Launch on OKX22.5.2026 14:30:00 CEST | Press release

OKX, a blockchain technology and trading company serving more than 120 million customers globally,and Intercontinental Exchange (NYSE: ICE), one of the world's leading providers of financial market technology and data powering global capital markets including the New York Stock Exchange, today announced plans for OKX to launch perpetual futures based on ICE's Brent Crude and WTI Crude energy benchmarks. The products are expected to be available to trade on OKX’s platform in jurisdictions where OKX is licensed to offer perpetual futures products. The new OKX contracts represent a major step forward in expanding regulated access to global commodity markets through digital asset infrastructure. This first product collaboration between OKX and ICE comes after the companies established a strategic relationship in March 2026. ICE operates some of the world’s leading exchanges, clearing houses and market data services across energy, commodities, fixed income and equities markets. ICE’s future

Enhertu® Recommended for Approval in the EU by CHMP for Patients with Previously Treated HER2 Positive Metastatic Solid Tumors22.5.2026 14:00:00 CEST | Press release

Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+) solid tumors who have received prior treatment and who have no satisfactory treatment options. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from patients with HER2 positive (IHC 3+) tumors in three phase 2 trials including DESTINY-PanTumor02,DESTINY-Lung01 andDESTINY-CRC02 where Enhertu demonstrated clinically meaningful responses across a broad range of tumors. The recommendation will now be reviewed by the European Commission, which has the authority

Future Health Challenge Awards USD 300,000 to Early Detection and Population Health Sensing Tools on Sidelines of World Health Assembly22.5.2026 13:45:00 CEST | Press release

Global teams recognised in the Future Health Challenge for solutions designed to detect health risks earlier and support faster health system decisions Future Health – A Global Initiative by Abu Dhabi and MIT Solve announce the winners of the inaugural Future Health ChallengeWinning solution equips frontline health workers in low-resource settings with mobile clinical decision-support tools, enabling earlier detection and more effective care deliveryTeams competed for a USD 200,000 grand prize and two USD 50,000 runner-up awards on the sidelines of the 79th World Health Assembly in GenevaWinners recognised for solutions advancing anticipatory, data-driven health systems Three global teams developing early detection and real-time population health monitoring solutions have secured a total of USD 300,000 on the sidelines of the 79th World Health Assembly. The winning solutions address critical challenges in early detection, continuous population insight and more timely decision making, s

Pivotal Trial Data for EP0031 (A400), a Next-Generation Selective RET Inhibitor (SRI), in RET Positive Advanced NSCLC, to be Presented at ASCO 202622.5.2026 11:18:00 CEST | Press release

Ellipses Pharma (“Ellipses”), a global oncology drug development company with a pipeline of innovative programmes, announced today that its partner, Kelun-Biotech, is presenting pivotal trial data for EP0031/A400, for the potential treatment of RET-fusion positive Non-Small Cell Lung Cancer (NSCLC), at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Chicago, May 29 to June 2. Efficacy and safety of lunbotinib (A400/EP0031), a next-generation selective RET inhibitor (SRI), from a pivotal phase Ⅱ study in patients with advanced RET-fusion positive non-small cell lung cancer (NSCLC), will be presented as an oral presentation scheduled on May 29, 2026, 14:36-14:48 local time (Abstract #8505: Lung Cancer – Non-Small Cell Metastatic). The oral presentation of these data at the prestigious ASCO annual meeting, represents another major milestone in the global development of EP0031/A400 as a next generation SRI. The data were generated in Kelun-Biotech’s Phase 2 study (NCT0

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye